Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-19

Clinical Trial Update: Safety and Tuberculin Conversion Following BCG Vaccination [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing safety and tuberculin conversion after BCG vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: PT Bio Farma | Conditions: BCG Vaccination Reaction | Phase 2 | Status: COMPLETED